{"database": "lobbying", "table": "lobbying_activities", "rows": [[798292, "9783509a-a2cb-495f-a8b3-9d0c8124de5e", "Q2", "INDEPENDENCE BLUE CROSS", 19172, "INDEPENDENCE BLUE CROSS", 2009, "second_quarter", "PHA", "Biogenerics/Generic Biologies: HR1427 \"Promoting Innovation and Access to Life-Saving Medicine Act\"\n\nCarve out of FEBHBP Rx benefits", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2009-07-17T14:39:31-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["798292"], "units": {}, "query_ms": 0.6890490185469389, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}